198 related articles for article (PubMed ID: 31637554)
1. Temporary loss of consciousness during cetuximab treatment of a patient with metastatic colon cancer: a case report.
Fukui T; Suzuki K; Tamaki S; Abe I; Endo Y; Ishikawa H; Kakizawa N; Watanabe F; Saito M; Tsujinaka S; Futsuhara K; Miyakura Y; Noda H; Rikiyama T
Surg Case Rep; 2019 Oct; 5(1):145. PubMed ID: 31637554
[TBL] [Abstract][Full Text] [Related]
2. Cetuximab therapy and symptomatic hypomagnesemia.
Schrag D; Chung KY; Flombaum C; Saltz L
J Natl Cancer Inst; 2005 Aug; 97(16):1221-4. PubMed ID: 16106027
[TBL] [Abstract][Full Text] [Related]
3. Identifying optimal magnesium replenishment points based on risk of severe hypomagnesemia in colorectal cancer patients treated with cetuximab or panitumumab.
Kimura M; Usami E; Teramachi H; Yoshimura T
Cancer Chemother Pharmacol; 2020 Sep; 86(3):383-391. PubMed ID: 32789758
[TBL] [Abstract][Full Text] [Related]
4. Hypomagnesemia is a reliable predictor for efficacy of anti-EGFR monoclonal antibody used in combination with first-line chemotherapy for metastatic colorectal cancer.
Fujii H; Iihara H; Suzuki A; Kobayashi R; Matsuhashi N; Takahashi T; Yoshida K; Itoh Y
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1209-15. PubMed ID: 27106835
[TBL] [Abstract][Full Text] [Related]
5. Cetuximab-induced hypomagnesemia in patients with colorectal cancer.
Fakih MG; Wilding G; Lombardo J
Clin Colorectal Cancer; 2006 Jul; 6(2):152-6. PubMed ID: 16945172
[TBL] [Abstract][Full Text] [Related]
6. [Effect of magnesium supplementation on early-stage hypomagnesemia in patients treated with cetuximab].
Demizu M; Ueda H; Osawa M; Chihara S; Igarashi T; Yano K; Kimura F; Tanaka N; Hiratsuka M
Gan To Kagaku Ryoho; 2013 Jul; 40(7):897-900. PubMed ID: 23863731
[TBL] [Abstract][Full Text] [Related]
7. Correlation between blood magnesium and calcium concentration in patients treated with an anti-EGFR antibody.
Tsujii T; Ogaki T; Nakae K; Imai K; Kise D; Tada S; Ueda H; Moriyama M
J Pharm Health Care Sci; 2016; 2():23. PubMed ID: 27688901
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between the Incidence of Hypomagnesemia and Acneiform Rash and the Therapeutic Effect of Anti-EGFR Monoclonal Antibody in Patients with Metastatic Colorectal Cancer].
Fujii H; Iihara H; Ishihara M; Matsuhashi N; Takahashi T; Yoshida K; Itoh Y
Gan To Kagaku Ryoho; 2016 Feb; 43(2):229-33. PubMed ID: 27067688
[TBL] [Abstract][Full Text] [Related]
9. Global T-wave inversions with isolated hypomagnesemia.
Tsai TF; Browning AC; Rutledge J
J Emerg Med; 2013 Oct; 45(4):e107-11. PubMed ID: 23896055
[TBL] [Abstract][Full Text] [Related]
10. Assessment of frequency and severity of hypomagnesemia in patients with metastatic colorectal cancer treated with cetuximab, with a review of the literature.
Streb J; Püsküllüoğlu M; Glanowska I; Ochenduszko S; Konopka K; Łupkowski R; Michalowska-Kaczmarczyk A; Bochenek-Cibor J; Majka M; Krzemieniecki K
Oncol Lett; 2015 Dec; 10(6):3749-3755. PubMed ID: 26788202
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of Factors Influencing the Development of Hypomagnesemia in Patients Receiving Cetuximab Therapy for Head and Neck Cancer].
Inose R; Takahashi K; Nishikawa T; Nagayama K
Yakugaku Zasshi; 2015; 135(12):1403-7. PubMed ID: 26632157
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor monoclonal antibodies for the treatment of metastatic colorectal cancer.
Jean GW; Shah SR
Pharmacotherapy; 2008 Jun; 28(6):742-54. PubMed ID: 18503402
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors of Cetuximab-Induced Hypomagnesemia and the Effect of Magnesium Prophylaxis in Patients with Head and Neck Cancer: A Retrospective Study.
Matsukane R; Isshiki R; Suetsugu K; Minami H; Hata K; Matsuo M; Egashira N; Hirota T; Nakagawa T; Ieiri I
Biol Pharm Bull; 2024; 47(3):732-738. PubMed ID: 38556358
[TBL] [Abstract][Full Text] [Related]
14. Importance of magnesium sulfate supplementation in the prevention of hypomagnesemia and hypocalcemia during chemoradiation in head and neck cancer.
Grašič Kuhar C; Strojan P; Zadnik V; Zakotnik B
J Trace Elem Med Biol; 2018 Dec; 50():327-331. PubMed ID: 30262299
[TBL] [Abstract][Full Text] [Related]
15. Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.
Wong SF
Clin Ther; 2005 Jun; 27(6):684-94. PubMed ID: 16117976
[TBL] [Abstract][Full Text] [Related]
16. Durable complete remission following anti-EGFR antibodies in recurrent metastatic colorectal cancer.
Boudrias-Dalle E; Cloutier M; Harvey M; Leblanc G; Besner-Morin O; Adam JP
J Oncol Pharm Pract; 2019 Jan; 25(1):239-243. PubMed ID: 28950807
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor inhibitor-induced hypomagnesemia: a survey of practice patterns among Canadian gastrointestinal medical oncologists.
Thangarasa T; Gotfrit J; Goodwin RA; Tang PA; Clemons M; Imbulgoda A; Vickers MM
Curr Oncol; 2019 Apr; 26(2):e162-e166. PubMed ID: 31043822
[TBL] [Abstract][Full Text] [Related]
18. Risk of anti-EGFR monoclonal antibody-related hypomagnesemia: systematic review and pooled analysis of randomized studies.
Petrelli F; Borgonovo K; Cabiddu M; Ghilardi M; Barni S
Expert Opin Drug Saf; 2012 May; 11 Suppl 1():S9-19. PubMed ID: 21843103
[TBL] [Abstract][Full Text] [Related]
19. Dual inhibition of the epidermal growth factor receptor with cetuximab, an IgG1 monoclonal antibody, and gefitinib, a tyrosine kinase inhibitor, in patients with refractory non-small cell lung cancer (NSCLC): a phase I study.
Ramalingam S; Forster J; Naret C; Evans T; Sulecki M; Lu H; Teegarden P; Weber MR; Belani CP
J Thorac Oncol; 2008 Mar; 3(3):258-64. PubMed ID: 18317068
[TBL] [Abstract][Full Text] [Related]
20. Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome.
Vincenzi B; Santini D; Galluzzo S; Russo A; Fulfaro F; Silletta M; Battistoni F; Rocci L; Zobel BB; Adamo V; Dicuonzo G; Tonini G
Clin Cancer Res; 2008 Jul; 14(13):4219-24. PubMed ID: 18594003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
